Nacuitys molecules are differentiated, prescription-quality, GMP-grade moieties, which, combined with innovative delivery technologies, are poised to address diseases and conditions involving oxidative stress including retinitis pigmentosa, cataract and cystinosis as well as rare neurological diseases
Proceed to next dose tier only when grade 1 events have resolved or the patient reports tolerance
Genera such as Lactococcus , Bifidobacterium , Lactobacillus , Bacteroides , Pseudomonas , Staphylococcus , Enterococcus , and Streptomyces can potentially also exhibit myrosinase-like activity
Targeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinoma